BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11738308)

  • 1. Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.
    Walter DH; Fichtlscherer S; Britten MB; Rosin P; Auch-Schwelk W; Schächinger V; Zeiher AM
    J Am Coll Cardiol; 2001 Dec; 38(7):2006-12. PubMed ID: 11738308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.
    Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1477-83. PubMed ID: 16308495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction.
    Walter DH; Fichtlscherer S; Britten MB; Auch-Schwelk W; Schächinger V; Zeiher AM
    Am J Cardiol; 2002 Jan; 89(1):1-6. PubMed ID: 11779513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.
    Walter DH; Fichtlscherer S; Sellwig M; Auch-Schwelk W; Schächinger V; Zeiher AM
    J Am Coll Cardiol; 2001 Mar; 37(3):839-46. PubMed ID: 11693760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
    Takamiya Y; Miura S; Kawamura A; Tanigawa H; Zhang B; Iwata A; Nishikawa H; Matsuo K; Shirai K; Saku K
    Coron Artery Dis; 2009 Jun; 20(4):288-94. PubMed ID: 19440067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
    Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina.
    Arimura T; Miura S; Ike A; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Saku K
    J Cardiol; 2012 Aug; 60(2):111-8. PubMed ID: 22542530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
    Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R
    JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perioperative intensive statin therapy improves outcomes in patients with ischemic stroke undergoing middle cerebral artery stent implantation].
    Gao JH; Gao XP; Pan SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):356-60. PubMed ID: 27063162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.
    Karaca I; Aydin K; Yavuzkir M; Ilkay E; Akbulut M; Isik A; Arslan N
    J Int Med Res; 2005; 33(4):389-96. PubMed ID: 16104442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged double antiplatelet therapy in a cohort of "de novo" diabetic patients treated with drug-eluting stent implantation.
    Mollichelli N; Morici N; Ambrogi F; Latib A; Boracchi P; Godino C; Ferri L; Ielasi A; Chieffo A; Montorfano M; Colombo A
    Am J Cardiol; 2010 May; 105(10):1395-401. PubMed ID: 20451684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
    Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of C-reactive protein on in-stent restenosis: a meta-analysis.
    Li JJ; Ren Y; Chen KJ; Yeung AC; Xu B; Ruan XM; Yang YJ; Chen JL; Gao RL
    Tex Heart Inst J; 2010; 37(1):49-57. PubMed ID: 20200627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.